Clinical Trials
9 trialsNCT04618081 2025-07-08
Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)
Celgene
Completed
NCT03433560 2024-05-14
An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)
Kyowa Kirin Co., Ltd.
Completed
NCT02921802 2022-06-14
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
Completed
NCT02922543 2022-06-14
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Celgene
Completed
NCT02135887 2020-12-22
MB-6
Microbio Co Ltd
Unknown
NCT03087370 2018-12-07
A Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome
X4 Pharmaceuticals
Withdrawn
NCT01060462 2014-05-15
Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients
Janssen Korea, Ltd., Korea
Completed
NCT01021683 2013-08-12
The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants
Janssen Korea, Ltd., Korea
Completed
NCT01706562 2013-02-20
A Study of Empirical Antifungal Therapy With Itraconazole
Janssen Korea, Ltd., Korea
Completed